TLSA
Tiziana Life Sciences LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$161.60M
P/E Ratio
—
EPS
$-0.12
Beta
0.37
52W High
$2.60
52W Low
$0.73
50-Day MA
$1.38
200-Day MA
$1.68
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Tiziana Life Sciences Ltd
Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the UK.
Fundamentals
| Revenue (TTM) | $-3.60M |
| Gross Profit (TTM) | 0 |
| EBITDA | $-18.46M |
| Operating Margin | 0.00% |
| Return on Equity | -232.30% |
| Return on Assets | -83.80% |
| Revenue/Share (TTM) | $-0.02 |
| Book Value | $0.08 |
| Price-to-Book | 17.36 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -5.98 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $127.25M |
| Float | $64.81M |
| % Insiders | 43.95% |
| % Institutions | 3.14% |
Historical Volatility
HV 10-Day
64.74%
HV 20-Day
76.58%
HV 30-Day
66.65%
HV 60-Day
78.72%
HV Rank
14.7%
Volatility is currently contracting
Data last updated: 4/9/2026